[13] These findings are further reinforced by pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS) database (n=48,214 reports), where GLP-1RA-related gastrointestinal adverse events, including nausea (9651 vs 38,030) and vomiting (4383 vs 17,062), were lower with combination therapy compared to GLP-1RA monotherapy, suggesting improved tolerability when metformin is added
People with obesity or overweight (without T2DM) showed significant weight loss
You can look up the lot number on its website
and my blood pressure and cholesterol have almost returned to normal
What This Means Practically When Hers or any telehealth platform offers compounded GLP-1 options, these are not Ozempic, Wegovy, Mounjaro, or Zepbound